Celldex Therapeutics
CLDX
$27.48
Share price
-0.16%
Change (1 day)
-11.49%
Change (1 year)
Categories
Earnings for Celldex Therapeutics (CLDX)
Earnings in 2023 (TTM): -$0.13 B
According to Celldex Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.13 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$69.15 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Celldex Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.13 B | 13.22% |
| 2022 | -$0.11 B | 54.88% |
| 2021 | -$69.15 M | 39.49% |
| 2020 | -$49.58 M | -9.08% |
| 2019 | -$54.53 M | -28.64% |
| 2018 | -$76.41 M | -30.11% |
| 2017 | -$0.11 B | -17.75% |
| 2016 | -$0.14 B | 2.61% |
| 2015 | -$0.13 B | 9.71% |
| 2014 | -$0.12 B | 46.46% |
| 2013 | -$80.63 M | |
| 2011 | -$43.01 M | 3492.65% |
| 2010 | -$1.2 M | -96.73% |
| 2009 | -$36.61 M | |
| 2006 | -$22.37 M | 18.56% |
| 2005 | -$18.87 M | 38.89% |
| 2004 | -$13.59 M | 15.75% |
| 2003 | -$11.74 M | -18.69% |
| 2002 | -$14.44 M | -41.22% |
| 2001 | -$24.56 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $24.22 B | -20,074.93% | 🇺🇸 USA |
 Amgen AMGN | $9.19 B | -7,683.89% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.96 B | -6,672.73% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | -$8.47 M | -93.02% | 🇺🇸 USA |
 Seagen
SGEN | -$0.76 B | 520.21% | 🇺🇸 USA |
 Agenus
AGEN | -$0.21 B | 69.86% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.48 B | 294.70% | 🇺🇸 USA |